•  
  •  
  •  
  •  

2026-08-12 07:18:37

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Enviro Infra Engineers Reports 49.1% Revenue Growth to ₹ 3,592 Million in Q1 FY27; PAT Rises 6.5% to ₹ 452 Million
  • Wanbury Limited Reports Q1 FY27 Revenue of ₹165.6 Crore; Refinances ₹205 Crore Debt to Cut Interest Costs
  • Popular Vehicles & Services Reports 44.6% YoY Revenue Growth to ₹1,903.1 Crore in Q1 FY27; Turns Profitable with ₹1.4 Crore PAT
  • Hirect Limited Reports 20.3% Revenue Growth in Q1 FY27; Standalone Net Profit Up 17.8% Amid Global Expansion
  • Delton Cables reports highest ever first quarterly Revenue, EBITDA & PAT

Keywords Selected:  USA

Stock Report

  • Lupin Announces the Approval of Sodium Zirconium Cyclosilicate for Oral Suspension in the United States
  • Elgi Compressors USA Inc receives tariff refund of $2.68 Mn
  • 3i Infotech Inc., USA receives order worth Rs. 1.47 crore
  • Blue Cloud Softech Solutions Ltd - USA Executes Five-Year Master Services Agreement for AI Services with SpaceX International Ltd, MY
  • Aurobindo Pharma USA Inc completes acquisition of Lannett Company, Inc
  • Waaree Energies' Clarifies U.S. Customs Determination
  • Glenmark Pharmaceuticals Inc., USA launches Methylene Blue Injection USP, 50 mg/10 mL (5 mg/mL) Single-Dose Vial
  • Lupin Pharmaceuticals, Inc, USA enters into settlement agreement with Humana Inc
  • Unichem Pharmaceuticals (USA) Issues Voluntary Recall of Buspirone Hydrochloride Tablets
  • 3i Infotech Inc., USA receives order worth Rs. 2.76 crores
  • 3i Infotech Inc., USA receives order worth approx. Rs. 1.63 crores
  • Glenmark Pharmaceuticals announces Strategic Shift to Direct Commercialization and Distribution of RYALTRIS® in the U.S.
  • Glenmark Therapeutics Inc., USA launches Fluticasone Propionate Nasal Spray USP, 50 mcg per spray (OTC)
  • 3i Infotech Inc., USA receives order worth Rs. 2.21 crores
  • Glenmark Pharmaceuticals Inc., USA to launch Sodium Phosphates Injection USP, 15 mM P/5 mL, 45 mM P/15 mL and 150 mM P/50 mL (3 mM P/mL) Single-Dose Vials
  • LT Foods Secures Major Relief in U.S. Countervailing Duty Review
  • Powerhouse Engines Selects Ramco Systems to Transform Engine MRO Operations
  • Lupin Launches Authorized Generic Version of Ravicti® in the United States
  • Glenmark Pharmaceuticals Inc., USA to launch Ropivacaine Hydrochloride Injection USP
  • Lupin gets one observation from USFDA for Somerset, New Jersey manufacturing facility
  • Emmforce Autotech Ltd secures prestigious order worth Rs. 10.50 crores
  • Optiemus Infracom and Ordinary Theory USA announce JV to Manufacture & Market 'Made in India' Smart Enterprise Hardware & Industrial Solutions
  • Waaree Energies' Continued Commitment to U.S. Manufacturing and Regulatory Compliance
  • Hexaware Technologies Ltd - Update on U.S. H1B Visa Regulation Changes

Latest Post

  • Enviro Infra Engineers Reports 49.1% Revenue Growth to ₹ 3,592 Million in Q1 FY27; PAT Rises 6.5% to ₹ 452 Million
  • Wanbury Limited Reports Q1 FY27 Revenue of ₹165.6 Crore; Refinances ₹205 Crore Debt to Cut Interest Costs
  • Popular Vehicles & Services Reports 44.6% YoY Revenue Growth to ₹1,903.1 Crore in Q1 FY27; Turns Profitable with ₹1.4 Crore PAT
  • Hirect Limited Reports 20.3% Revenue Growth in Q1 FY27; Standalone Net Profit Up 17.8% Amid Global Expansion
  • Delton Cables reports highest ever first quarterly Revenue, EBITDA & PAT


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025